medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2014, Number 3

<< Back Next >>

Rev Esp Med Quir 2014; 19 (3)

Gestational diabetes and metformin

San Martín-Herrasti JM, Alcázar-Álvarez LS, Serrano-Berrones MÁ, Tirado-Chávez J, Castro-Herrera GA

Language: Spanish
References: 33
Page: 347-355
PDF size: 451.99 Kb.


ABSTRACT

Background: The global prevalence of Gestational Diabetes Mellitus (GDM) is estimated to be 14%. Whenever the development of diabetes is observed in younger people which is more frequent diagnosis of GDM. The management of GDM with insulin which is the gold standard is associated with increased cost and complications, metformin is the main hypoglycemic used in patients with Diabetes Mellitus and is a category B drug for use in pregnancy FDA. The usefulness of metformin in pregnancy is discussed.
Material and methods: Searches the available literature the last 7 years to answer related to the utility of metformin in patients with GDM questions.
Results: It is seen that is accepted use of metformin in 76.6% of patients, the use of metformin to control was effective in 53.7% of cases and when insulin was added were less requirements and complications when compared only with the use of insulin. The prevalence of complications or side effects is low, so that its use in pregnancy is safe.
Conclusion: Metformin is a safe drug, with a high rate of effectiveness, which can be considered as the first option in the medical management of GDM.


REFERENCES

  1. Guía de Práctica Clínica. Diagnóstico y tratamiento de la Diabetes Mellitus en el embarazo, México: Secretaria de Salud; 209.

  2. Serti T, Brown A., Feinglos M. Gestacional Diabetes Mellitus. Clinical Diabetes 2005;23:17-24.

  3. ADA Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010;34:S62–S6.

  4. Gui J, Liu Q, Feng L.Metformin vs insulin in the management of gestational diabetes: a meta-analysis.PLoSOne. 2013;27;8(5):e64585.

  5. Ramírez M., Diabetes Mellitus Gestacional. Experiencia de una Institución de tercer Nivel de Atención. GinecolObstetMex 2005;73:484-491.

  6. Norman RJ, Wang JX, Hague W. Should we continue or stop insulin sensitizing drugs during pregnancy? CurrOpinObstetGynecol 2004;16:245–250.

  7. Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, Hankins GD, Ahmed MS Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol. 2006;195:1081–1085.

  8. Kovo M, Haroutiunian S, Feldman N, Hoffman A, Glezerman M. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. Eur J Obstet Gynecol Reprod Biol 2008;136:29–33.

  9. Castro Serna D. y Castro Martínez M. G. Bioguanidas. Med Int Mex 2006; 22:439-49

  10. Berggren E. K and Boggess K.A: Oral Agents for the Management of Gestational Diabetes. Clin Obstet Gynecol 2013;56:827.836

  11. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003–2015.

  12. Marques P, Carvalho MR, Pino L, Guerra S. Metformin safety in the management of gestational diabetes. Endocr Pract 2014;105:1-21.

  13. Su DF. Wang XY. Metformin versus insulin in the management of gestational diabetes a sistemic review and meta analysis. Diabetes Res Clin Pract 2014:104:353-357.

  14. Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi SG, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int J Prev Med 2013;4(3):327-33.

  15. Gui J, Liu Q, Feng L Metformin vs Insulin in the Management of Gestational Diabetes: A Meta-Analysis. PLoS One. doi: 10.1371/journal.pone.0064585. Print 2013.PLoS ONE 2013:8:e64585.

  16. Kirpichnikov D, Mcfarlane S, Sowers JR. Metformin: An update. Ann Intern Med 2002;137:25-33.

  17. Navneet M and Seshiah. Gestational Diabetes Mellitus: Non-insulin management. Indian J Endocrinol Metab 2011;15:284–293.

  18. Serlin DC, Serlin and Lash RW. Diagnosis and Management of Gestational Diabetes Mellitus. Am Fam Physician 2009;80:57-62.

  19. Corbould A, Swinton F, Radford A, Campbell J, McBeath S, Dennis A. Fasting blood glucose predicts response to extended-release metformin in Gestational Diabetes Mellitus. Aust N Z J Obstet Gynaecol 2013;53:125-9.

  20. Tertti K, Ekblad U, Koskinen P, Vahlberg T, Rönnemaa T. Metformin vs. insulin in Gestational Diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013;15:246-51.

  21. Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy.Diabet Med 2014;31:282-91.

  22. Lautatzis ME, Goulis DG, Vrontakis M. Efficacy and safety of metformin during pregnancy in women with Gestational Diabetes Mellitus or polycystic ovary syndrome: a systematic review. Metabolism 2013;62:1522-34.

  23. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RP. Randomized trial of metformin vs insulin in the management of Gestational Diabetes. Am J Obstet Gynecol 2013;209:34.e1-7.

  24. Hickman MA, McBride R, Boggess KA, Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt Diabetes: a randomized controlled trial. Am J Perinatol 2013;30:483-90.

  25. Niromanesh S, Alavi A, Sharbaf FR, Amjadi N, Moosavi S, et al. (2012) Metformin compared with insulin in the management of Gestational Diabetes Mellitus: A randomized clinical trial. Diabetes Res Clin Pract 98:422–429.

  26. Silva JC, Faccin DR, Coral MG, Bertini A. Perinatal impact of the use of metformin and gluburide for the treatment of Gestational Diabetes Mellitus. J Perinatol Med 2012;40:225-8.

  27. Gandhi P, Bustani R, Madhuvrata P, Farell T. Introduccion of metformin for Gestational Diabetes Mellitus in Clinical Practice: Has it had an impact? Eur J Obstet Gynecol Reprod Biol 2012;160:147-50.

  28. Magon N and Seshiah V. Gestational Diabetes Mellitus non-insulin management. Indian J Endocrinol Metab 2011;15:284-293.

  29. Guh JE, Sadler L, Rowan J. Metformin for Gestational Diabetes in routine clinical practice. Diabet Med 2011;28:1082-7.

  30. Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, et al. Metformin should be considered in the treatment of Gestational Diabetes: a prospective randomised study. BJOG 2011;118:880–885.

  31. Silva JC, Pacheco C, Bizato J, De Souza BV, ribero TE, Bertini AM. Metformin compared with gliburide for the management of Gestational Diabetes. Int J Gynaecol Obstet 2010;111:37-40.

  32. Piacquadio K, Hollingsworth DR, Murphy H. effects of in utero exposure to oral hyopoglycaemic drugs. Lancet 1991;338:860-9.

  33. Gilbert C, Valois M, Karen G. Pregnancy outcome after first-trimester exposure to metformina a meta-analysis. Fertil Steril 2006;86:658-63.




2020     |     www.medigraphic.com